试验雷达 AI | ||
|---|---|---|
临床试验 NCT07256522 针对扳机指，Splint Therapy，Paraffin Bath，Peloidotherapy，疗效和安全性，Randomised Clinical Trial目前招募中。请查看临床试验雷达卡片视图和 AI 发现工具了解所有详情，或在此提出任何问题。 | ||
Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger
All patients will receive education about the disease and activity modification. The finger joint-restricting splint and exercises will be applied for 6 weeks. Evaluations will be conducted at baseline, at the end of the 3rd week, and at the end of the 6th week by a blinded assessor. No analgesic or anti-inflammatory medication will be permitted during the study, and patients will be instructed to avoid using analgesics within 24 hours prior to each assessment.
The first group will be instructed to use a static finger splint that blocks the proximal interphalangeal joint for 6 weeks and will also follow a home exercise program. The second group will receive paraffin bath therapy for 20 minutes per day, 15 sessions over 3 weeks, together with a home exercise program. The third group will receive peloidotherapy at 45°C for 20 minutes per day, consisting of 15 sessions over 3 weeks, in conjunction with a home exercise program.
A static finger splint that restricts the proximal interphalangeal joint and maintains it in extension will be provided to the patients. They will be instructed to wear the splint continuously during both day and night, removing it only for hygiene or essential needs. The splint will be worn for 6 weeks until the completion of the study, and the daily duration of splint use will be recorded for each patient.
The home exercise program will include finger passive and active range of motion exercises (passive fist-making and active range of motion without triggering), tendon gliding, self-administered gentle A1 pulley stretching, and gentle deep circular massage. The exercises will be demonstrated to each patient in practice by a physician or physiotherapist and taught using printed visual materials. Patients will be specifically instructed, encouraged, and monitored to ensure exercise adherence. Those with an adherence rate below 70-75% will be excluded from the study.
All patients will receive education about the disease and will be advised on activity modification. Evaluations will be performed before treatment, at the end of the 3rd week, and at the end of the 6th week. A blinded assessor will conduct detailed examinations and evaluate the groups in terms of the study's primary and secondary outcome measures.
Patients' baseline sociodemographic and clinical data will be recorded, and a detailed physical examination will be performed. Pain intensity, trigger frequency, severity, and functional impact will be evaluated using a 0-10 Visual Analog Scale (VAS). Clinical staging of the trigger finger will be determined according to Green's classification (Grades 1-4). Patient compliance with orthotic use and exercise will be documented. Ultrasound assessments, including tendons thickness, A1 pulley thickness, and the presence of effusion (semiquantitative) will be performed by a blinded researcher with over five years of experience in musculoskeletal ultrasonography. In addition, patients' satisfaction levels will be evaluated and recorded using the Patient Global Improvement Scale. Any potential treatment-related undesirable effects effects will also be documented.
No analgesic or anti-inflammatory medication will be prescribed during the treatment period. Additionally, patients will be informed not to take any analgesic medication within 24 hours before the assessments.
Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger. A Prospective, Randomized, Controlled Study
- KonyaBeyhekimTRH2025/5634
splint therapy
paraffin bath
peloidotherapy
Randomised Controlled Study
| 参与者组/试验组 | 干预措施/治疗方法 |
|---|---|
实验性Finger orthosis The group receiving the finger joint-blocking orthosis | Finger Orthosis Joint-blocking finger orthosis plus home-based exercise therapy |
实验性Paraffin bath The group receiving paraffin bath therapy | Paraffin Bath Paraffin bath plus home-based exercise therapy |
实验性Peloidotherapy The group receiving peloidotherapy | Peloidotherapy Peloidotherapy plus home-based exercise therapy |
| 结果指标 | 度量标准描述 | 时间框架 |
|---|---|---|
VAS pain | VAS pain: 0 no pain; 10 unbearable/max. pain. | Baseline, week 3 and week 6 |
Green's classification (Grades 1-4) | Trigger finger classified according to Green's classification (Grades 1-4) Grade 1 - Pretriggering: Pain in the palm and tenderness over the A1 pulley, with a history of triggering not demonstrable on examination.
Grade 2 - Active Triggering: Triggering is clinically evident, but the patient can actively extend the finger.
Grade 3 - Passive Triggering:
3a: Locking is present and requires passive extension.
3b: Locking is present, and the patient cannot actively flex the finger.
Grade 4 - Contracture: The finger is completely locked with a fixed flexion contracture at the PIP joint. | Baseline, week 2 and week 6 |
Michigan Hand Outcomes Questionnaire (MHQ) | The Michigan Hand Outcomes Questionnaire (MHQ) is a comprehensive self-reported questionnaire developed to evaluate hand function, pain, and patient satisfaction. It is used to assess the functional status of individuals with upper extremity disorders and consists of six subscales: Overall Hand Function, Activities of Daily Living, Work Performance, Pain, Aesthetics, and Satisfaction. The Turkish version of the MHQ has undergone linguistic and cultural adaptation processes, and its validity and reliability have been established. Studies have demonstrated that the Turkish MHQ has high internal consistency and test-retest reliability, supporting its use in both clinical practice and research for assessing hand and wrist problems. The MHQ is scored on a scale ranging from 1 to 100. Except for the pain subscale, higher scores indicate better hand function and satisfaction, whereas higher pain scores represent greater pain intensity. The overall hand health status is determined by cal | Baseline, week 2 and week 6 |
| 结果指标 | 度量标准描述 | 时间框架 |
|---|---|---|
Patient Global Impression of Change | Patient Global Impression of Change (Improvement):
1: Very much improved 2: Much improved 3: Minimally improved 4: No change 5: Minimally worse 6: Much worse 7: Very much worse | Week 2 and week 6 |
Ultrasonographic evaluation of the trigger finger | Ultrasonographic evaluation of the trigger finger will be performed using a LA2-14A transducer. The hand and forearm will be positioned with the palmar surface facing upward (full supination) and the wrist maintained in a neutral position. The ultrasound examination will begin in the longitudinal plane and then proceed to the transverse plane. The MCP joint, flexor tendons, and volar will be identified. At the level of the MCP joint, the transducer will be rotated to obtain a transverse image along the long axis of the flexor digitorum tendons. The thin layer located between the hyperechoic A1 pulley and the hyperechoic surface of the flexor digitorum tendons will represent the synovial fluid space, appearing as a hypoechoic band on ultrasonography. The thickness of the A1 pulley will be defined as the distance between its superior and inferior margins, including the hyperechoic region. The maximum thickness of the A1 pulley above the MCP joint will be measured and recorded. | Baseline, week 2 and week 6 |
Ultrasonographic evaluation of the trigger finger | The cross-sectional areas (CSAs) of the flexor digitorum tendons will also be measured using a similar approach as described above. At the level of the MCP joint, the maximum CSAs of the flexor digitorum tendons will be manually traced in the transverse view along the outer hyperechoic contour. The average of three measurements will be calculated and recorded. Similar measurements will be performed on the corresponding finger of the contralateral healthy hand and recorded for comparison. | Baseline, week 2 and week 6 |
- Being between 18 and 75 years of age and willing to participate in the study
- Having a diagnosis of idiopathic single trigger finger, Grade 2-3
- Patients with triggering in more than one finger
- Patients with triggering at the A3 pulley or with Grade 1 or Grade 4 trigger finger
- Patients with thumb (pollex) trigger finger
- Patients who have undergone any injection or interventional procedure (release surgery) for trigger finger within the past 6 months
- Patients who have received physical therapy for the hand within the past 6 months
- Patients currently using corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs)
- Patients with inflammatory or autoimmune rheumatologic diseases such as rheumatoid arthritis, systemic lupus erythematosus, gout, or psoriatic arthritis
- Patients with other musculoskeletal disorders (e.g., carpal tunnel syndrome, de Quervain's tenosynovitis, symptomatic hand osteoarthritis, or Dupuytren's contracture) or neurological diseases (e.g., stroke-related hemiparesis, spinal cord injury, brachial plexus injury, multiple sclerosis, or Parkinsonism) affecting the same hand
- Patients with musculoskeletal disorders causing pain and/or limitation in the proximal upper extremity on the affected side (e.g., periarthritis, lateral epicondylitis, mononeuropathy, or radiculopathy)
- Patients with significant metabolic diseases (e.g., hypothyroidism, Cushing's syndrome, or uncontrolled diabetes)
- Patients with any condition that may interfere with treatment, such as open wounds, rashes, local infections, or active malignant disease of the hand
- Patients with a history of hand trauma (chronic or repetitive)
- Patients unwilling to complete the self-assessment questionnaires either independently or with assistance
- Pregnant women
Konya Beyhekim Training and Research HospitalKonya